The short-read sequencing market size is projected to be valued at US$ 6,322.03 million in 2023 and is expected to rise to US$ 34,401.22 million by 2033. The sales of short-read sequencing are projected to expand at a significant CAGR of 18.46% during the forecast period.
Various Factors Propelling the demand for Short-Read Sequencing are
The short-read sequencing market refers to DNA sequencing technologies that generate relatively short DNA fragments, typically 50-600 base pairs.
Short-read sequencing techniques are widely used in genomic research, clinical diagnostics, and other applications requiring high-throughput DNA sequencing.
The rising prevalence of rare and complex diseases in the population is causing healthcare providers to implement novel cures. The growing awareness of people's strong desire to understand their genomics fuels global demand for short-read sequencing techniques.
The short-read sequencing market has experienced significant growth in recent years, driven by advances in sequencing technology, increasing research and clinical demand for genomic analysis, and decreasing sequencing costs.
The short-read sequencing market is a subset of the broad DNA sequencing market and is characterized by the rapid and inexpensive generation of large amounts of sequencing data.
The short-read sequencing market has applications in various fields, such as genetic research, clinical diagnostics, drug discovery, agriculture, and forensics.
The utilization of cloud computing as a potential data management service and high growth potential in untapped emerging markets are expected to create lucrative opportunities for market participants.
Manufacturers in the market provide a wide range of sequencing platforms and related products and services, such as sample preparation kits, sequencing reagents, and bioinformatics software. Furthermore, the growing adoption of short-read techniques due to their low cost and short run times boosts the global market.
Overall, the short-read sequencing market is expected to continue growing prominently in the coming years owing to advances in sequencing technology, increasing demand for genomic analysis, and new applications and use cases.
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Short-Read Sequencing Market Outlook Compared to 2023 to 2033 Forecast
The short-read sequencing market was valued at US$ 5,341.3 million in 2022, with a substantial growth trajectory of 17.97% between the analysis period of 2018 to 2022.
Notable sequencing technology advances, such as accuracy, throughput, and read lengths, are driving the short-read sequencing market. Sequencing is becoming more accessible and cost-effective, allowing it to be used in various applications.
Future Market Insights expects the short-read sequencing market to expand at a CAGR of 18.46% from 2023 to 2033. The growth can be attributed to the different reasons discussed below.
One of the key factors driving the demand for the short-read sequencing market is the increasing prevalence of genetic diseases.
According to World Economic Forum data (February 2020), almost 10% of the world's population (475 million people) is affected by rare diseases. Rare diseases are often difficult to recognize and go undetected or lead to misdiagnosis. DNA sequencing, like short-read sequencing, offers advantages such as detecting multiple variant types in a single assay, improving the diagnostic field and operational efficiency. Recognizing these benefits of DNA sequencing, some countries focus on genomic programs to provide better.
The short-read sequencing market is likely to grow significantly during the forecast period (2023 to 2033) due to the increasing prevalence of rare genetic diseases and the increasing emphasis on identifying genetic mutations.
Considering the abovementioned factors, FMI opines that the short-read sequencing market is likely to witness a market value of US$ 34,401.22 million by the end of 2033.
Short-read Sequencing has Become a Key Component in Advancing the Concept of Precision Medicine
The concept of 'precision medicine', which individualizes treatment plans according to tumours' biological behaviour, is considered a new approach to cancer treatment. The clinical applications of precision medicine are diverse and include screening, diagnosis, prognosis, prediction of therapeutic response and resistance, early detection of recurrence/metastasis, and biological cancer stratification.
Precision medicine in cancer treatment aims to achieve therapeutic efficacy in subsets of patients who exhibit specific molecular/predictive biomarkers. Tailoring therapy to a patient's genetic makeup has gained wide acceptance and attention from physicians.
Advanced sequencing technologies, such as next-generation sequencing, aid in cancer gene mapping, tumor analysis, and the development of specific therapeutics. In addition, it has the advantage of simultaneously analyzing a wide range of genetic alterations, including copy number variations, mutations, fusions of multiple genes, and translocations. This has led to personalized medicines being approved by regulatory bodies around the world. For example,
According to the USA Food and Drug Administration, 39% of all drugs approved in 2020 were classified as personalized medicine. Therefore, the increasing importance of precision medicine and its advantages in disease control are expected to contribute to the growth of the DNA sequencing market during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Comparative View of the Short-Read Sequencing Market
Short-Read Sequencing Market:
Attributes
Short-Read Sequencing Market
CAGR (2023 to 2033)
18.46%
Market Value (2033)
US$ 34,401.22 million
Growth Factor
The rising prevalence of rare and complex diseases in the population is causing healthcare providers to implement novel cures. The growing awareness about people's strong desire to understand their genomics is fueling global demand for short-read sequencing techniques
Opportunity
The growing adoption of short-read techniques due to their low cost and short run times boosts the global market.
Small Cell Lung Cancer (SCLC) Treatment Market:
Attributes
Small Cell Lung Cancer (SCLC) Treatment Market
CAGR (2023 to 2033)
13.1%
Market Value (2033)
US$ 3.47 million
Growth Factor
The increasing need for personalized therapy, the availability of extremely effective drugs, the growing elderly population, and the prevalence of unhealthy habits are the primary factors driving the global small cell lung cancer therapeutics market.
Opportunity
Increased funding for research and the development of novel treatments, increased pollution as a result of rapid industrialization, and an increase in the number of smokers are all factors contributing to the rising prevalence of lung cancer.
Infectious Disease Diagnostics Market:
Attributes
Infectious Disease Diagnostics Market
CAGR (2023 to 2033)
4.3%
Market Value (2033)
US$ 747.3 million
Growth Factor
Small bore connectors are devices that connect medical equipment such as syringes, tubing, drips, and others in order to deliver gases, medicines, and fluids to patients. As a result, increased emphasis on the use of high-performance medical devices to improve patient safety and reduce medical errors is expected to favor market growth.
Opportunity
Since small-bore connectors are widely used to deliver oxygen and other liquid medications to patients suffering from these diseases, the rising prevalence of respiratory disorders is expected to drive market growth in the coming years.
Category-wise Insights of Short-read Sequencing
Development of a Short-read Platform Assists Oncology Researchers with Sensitive and Specific Targeted Sequence Analysis Insights.
In 2022, the targeted sequencing and resequencing segment held a significant market share of 68.21%. Short-read sequencing of cancer-associated genes from multiple genome sets has been improved by advanced platforms. This enables medical specialists to understand the genetic makeup of tumor cells and recommend appropriate therapeutics.
In 2022, the Consumables Segment Xccounted for 62.65% of the Short-Read Sequencing Industry.
Pipettes, tips, and assay kits have a wide range of applications in short-read procedures, driving the market. The main market share can be attributed to the following:
High research and development investments in genomic research.
Rising demand for high-quality short-read compatible consumables in academic research and biopharmaceutical research and development.
These elements are expected to drive the segment during the forecast period.
Data Analysis is Expected to Secure a CAGR of 20.49% between 2023 and 2033, Making it the Lucrative Segment in the Short-Read Sequencing Industry.
Data analysis allows for the analysis of gene expression, which can be used to study disease progression and diagnosis. It is crucial in clinical research studies. QIAGEN Digital Insights, for example, launched the NGS data analysis platform in January 2023 to perform whole genome analysis for clinical research studies in 25 minutes. These product launches have the potential to significantly boost segment growth in the coming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Regional Analysis of the Short-Read Sequencing Market
The Presence of Leading Corporations Increased Public Funding, and an Increase in Research Activities in the Region is Contributing to the Region's Expansion of Short-Read Techniques.
North America held a prominent share of the short-read sequencing industry in 2022, accounting for almost 49.77% of the market size. The region is paving the way for countries to use DNA sequencing for healthcare and diagnostics in the medical industry. The United States and Canada are the region's top revenue contributors to the DNA sequencing market. The market cost of sequencing has decreased as technology has advanced. This is increasing patient interest in personal DNA sequencing for future personalized treatment.
Germany is Anticipated to Expand at an 8.1% CAGR within Europe.
Europe is a significant market for short-read sequencing, owing to the presence of leading sequencing technology companies such as Oxford Nanopore Technologies and Qiagen, as well as a strong research and development infrastructure. Growing demand for genomic analysis in clinical diagnostics, personalized medicine, and agriculture is also a feature of the region.
China, the World's Second-largest Economy, is Expected to Reach the Market Size of US$3.5 billion by 2027, Expanding at a CAGR of 9.3% during the Analysis Period.
This can be attributed to the region's increased research activities. The growing interest of key global players in increasing their regional revenues by expanding into the region's emerging markets also contributes toward regional growth. Regional players are also increasing their presence in the global short-read sequencing industry. Developing countries are growing more prominently in terms of capacity expansion than key Western markets.
Competitive Landscape/Key Players Operating in Short-Read Sequencing Market
The short-read sequencing market is highly competitive and is characterized by the presence of several key players, including
Illumina, Inc.: Illumina is the dominant player in the short-read sequencing market, with a market share of over 70%. The company offers a range of sequencing instruments, reagents, and software, including the popular NovaSeq and HiSeq sequencing systems.
Thermo Fisher Scientific, Inc.: Thermo Fisher Scientific is a leading provider of sequencing instruments, reagents, and software, including the Ion Torrent sequencing system. The company has a strong presence in the clinical diagnostics and research markets.
Oxford Nanopore Technologies, Ltd.: Oxford Nanopore Technologies is a leading provider of nanopore-based sequencing technology, including the portable MinION sequencing system. The company has a strong presence in the research market and is notably expanding into clinical diagnostics and other applications.
BGI Group: BGI Group is a leading provider of sequencing services and instruments, including the BGISEQ sequencing system. The company has a strong presence in China and is significantly expanding into other markets.
Pacific Biosciences of California, Inc.: Pacific Biosciences of California is a provider of long-read sequencing technology, including the Sequel II and Sequel IIe sequencing systems. The company has a strong presence in the research market and is expanding into clinical diagnostics and other applications.
Other key players operating in the market include Qiagen N.V., PerkinElmer, Inc., Agilent Technologies, Inc., and Eurofins Scientific SE.
The short-read sequencing market is characterized by ongoing innovation, with new products and technologies being introduced on a regular basis. Key players in the market are investing heavily in research and development to maintain their competitive edge and expand their presence in new and existing markets.
Recent Developments
PacBio announced the release of two genome sequencing systems, the Revio long-read sequencing system, and the Onso short-read sequencing system, in October 2022. Revio also includes deep-learning methods for detecting DNA methylation in regular sequencing libraries.
Element Biosciences revealed technical details about its long-awaited Aviti DNA sequencer in March 2022. The new benchtop instrument uses a variation on sequencing-by-synthesis chemistry, which Element claims reduces reagent usage and costs around USD 7 per GB.
Scope of the Report
Attributes
Details
Growth Rate
CAGR of 18.46% from 2023 to 2033
Base Year of Estimation
2022
Historical Data
2018 to 2022
Forecast Period
2023 to 2033
Quantitative Units
Revenue in US$ million and Volume in Units and F-CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered
By Product
By Workflow
By Application
By End-use
By Region
Regions Covered
North America
Latin America
Europe
East Asia
South Asia
The Middle East & Africa
Oceania
Key Countries Profiled
The United States
Canada
Brazil
Mexico
Germany
Italy
France
The United Kingdom
Spain
Russia
China
Japan
India
GCC Countries
Australia
Key Companies Profiled
Illumina, Inc.; Thermo Fisher Scientific, Inc.; Pacific Biosciences of California, Inc.; BGI; QIAGEN; Agilent Technologies; PerkinElmer, Inc.; ProPhase Labs, Inc. (Nebula Genomics); Psomagen; Azenta US, Inc. (GENEWIZ)
Customization & Pricing
Available upon Request
Key Segments Covered in the Short-Read Sequencing Market Report
Product Outlook:
Instruments
Consumables
Services
Workflow Outlook:
Pre-Sequencing
Sequencing
Data Analysis
Application Outlook:
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing
DNA-based
RNA-based
Others
End-use Outlook:
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region:
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
The Middle East & Africa (MEA)
Frequently Asked Questions
What was the Short-read Sequencing Market’s CAGR from 2018 to 2022?
From 2018 to 2022, global sales increased at a CAGR of 17.97%.
What will be the market's CAGR between 2023 and 2033?
The market is to continue to climb at an 18.46% CAGR through 2033.
How huge may the Short-Read Sequencing Market be in 2033?
The market is forecast to attain US$ 34,401.22 million by 2033.
What is the current Short-Read Sequencing Market valuation?
The market is estimated to be valued at US$ 6,322.03 million in 2023.
Which workflow segment to lead the market?
The targeted sequencing and resequencing sector make up 68.21% of the market share.
Which product segment ought to control the market?
The consumables segment constitutes 62.65% of the market share.
Table of Content
1. Executive Summary | Short-read Sequencing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Instruments
5.3.2. Consumables
5.3.3. Services
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033
6.3.1. Pre-Sequencing
6.3.2. Sequencing
6.3.3. Data Analysis
6.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Whole Genome Sequencing
7.3.2. Whole Exome Sequencing
7.3.3. Targeted Sequencing & Resequencing
7.3.4. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2023 to 2033
8.3.1. Academic & Research Institutes
8.3.2. Hospitals & Clinics
8.3.3. Pharmaceutical & Biotechnology Companies
8.4. Y-o-Y Growth Trend Analysis By End-Use, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End-Use, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Workflow
10.2.4. By Application
10.2.5. By End-Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Workflow
10.3.4. By Application
10.3.5. By End-Use
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Workflow
11.2.4. By Application
11.2.5. By End-Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Workflow
11.3.4. By Application
11.3.5. By End-Use
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product
12.2.3. By Workflow
12.2.4. By Application
12.2.5. By End-Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Workflow
12.3.4. By Application
12.3.5. By End-Use
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Product
13.2.3. By Workflow
13.2.4. By Application
13.2.5. By End-Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Workflow
13.3.4. By Application
13.3.5. By End-Use
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Workflow
14.2.4. By Application
14.2.5. By End-Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Workflow
14.3.4. By Application
14.3.5. By End-Use
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Product
15.2.3. By Workflow
15.2.4. By Application
15.2.5. By End-Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Workflow
15.3.4. By Application
15.3.5. By End-Use
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product
16.2.3. By Workflow
16.2.4. By Application
16.2.5. By End-Use
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Workflow
16.3.4. By Application
16.3.5. By End-Use
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Workflow
17.1.2.3. By Application
17.1.2.4. By End-Use
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Workflow
17.2.2.3. By Application
17.2.2.4. By End-Use
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Workflow
17.3.2.3. By Application
17.3.2.4. By End-Use
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Workflow
17.4.2.3. By Application
17.4.2.4. By End-Use
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Workflow
17.5.2.3. By Application
17.5.2.4. By End-Use
17.6. United kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Workflow
17.6.2.3. By Application
17.6.2.4. By End-Use
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Workflow
17.7.2.3. By Application
17.7.2.4. By End-Use
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Workflow
17.8.2.3. By Application
17.8.2.4. By End-Use
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Workflow
17.9.2.3. By Application
17.9.2.4. By End-Use
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Workflow
17.10.2.3. By Application
17.10.2.4. By End-Use
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Workflow
17.11.2.3. By Application
17.11.2.4. By End-Use
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Workflow
17.12.2.3. By Application
17.12.2.4. By End-Use
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Workflow
17.13.2.3. By Application
17.13.2.4. By End-Use
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Workflow
17.14.2.3. By Application
17.14.2.4. By End-Use
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Workflow
17.15.2.3. By Application
17.15.2.4. By End-Use
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product
17.16.2.2. By Workflow
17.16.2.3. By Application
17.16.2.4. By End-Use
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product
17.17.2.2. By Workflow
17.17.2.3. By Application
17.17.2.4. By End-Use
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product
17.18.2.2. By Workflow
17.18.2.3. By Application
17.18.2.4. By End-Use
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product
17.19.2.2. By Workflow
17.19.2.3. By Application
17.19.2.4. By End-Use
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product
17.20.2.2. By Workflow
17.20.2.3. By Application
17.20.2.4. By End-Use
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product
17.21.2.2. By Workflow
17.21.2.3. By Application
17.21.2.4. By End-Use
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Workflow
18.3.4. By Application
18.3.5. By End-Use
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Illumina, Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Thermo Fisher Scientific, Inc.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Pacific Biosciences of California, Inc.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. BGI
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. QIAGEN
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Agilent Technologies
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Psomagen
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Azenta US, Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. PerkinElmer, Inc.
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. ProPhase Labs, Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used21. Research Methodology
